BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Statement from J. Craig Venter, Ph.D., on the Presidential Commission for the Study of Bioethical Issues Report, 'New Directions: The Ethics of Synthetic Biology and Emerging Technologies'


12/16/2010 6:44:19 AM

ROCKVILLE, Md. and LA JOLLA, Calif., Dec. 16, 2010 /PRNewswire-USNewswire/ -- "The J. Craig Venter Institute (JCVI) commends the Presidential Commission for the Study of Bioethical Issues (Commission) for their extensive work that resulted in their report on the ethical and societal issues raised by synthetic biology and genomics. We believe that the Commission's report is comprehensive and that their recommendations are wise, warranted and restrained which will help to ensure that this young field of research will flourish in a positive manner.

"I and my team at the JCVI have been, since our earliest synthetic genomics experiments, focused on and concerned with the applications and advances in this research in tandem with the ethical and societal implications of our work. We have engaged in a dialogue since 1995 with a variety of public audiences including legislators, bioethicists, non-governmental groups, and the general public. We believe that the new report from the Commission is very positive for this field and we look forward to continuing to work with the Commission and all those engaged in the work of reviewing and assessing this field. The JCVI is committed to advancing this field for the benefit of society."

For more information and background information on the synthetic genomics policy and scientific research at JCVI please go to:

http://www.jcvi.org/cms/research/projects/first-self-replicating-synthetic-bacterial-cell/overview/

SOURCE J. Craig Venter Institute



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES